Tags :4Bio Medicamentos

Trench Rossi Watanabe advised Profarma on the acquisition of 100% of the equity of 4Bio Medicamentos, formerly owned by RD Saúde, in a transaction valued at approximately BRL 600 million (US$ 113.7 million). BMA advised Raia Drogasil. 4